Literature DB >> 8807864

Amyloid probes based on Congo Red distinguish between fibrils comprising different peptides.

T T Ashburn1, H Han, B F McGuinness, P T Lansbury.   

Abstract

BACKGROUND: Amyloid plaques, which characterize degenerating tissue in Alzheimer's disease (brain) and type II diabetes (pancreas), were first visualized by staining with the dye Congo Red (CR). The ability of CR to recognize amyloid fibrils comprising diverse proteins suggests that the binding site includes an unidentified structural feature common to all amyloid fibrils. We set out to design and synthesize analogs of CR that could distinguish between fibrils comprising different peptides.
RESULTS: Relative affinities of several CR analogs for two model amyloid fibrils were measured and compared to that of CR. Amyloid fibrils comprising peptides based on the critical carboxyl terminus of the Alzheimer's disease amyloid protein beta1-42 (beta34-42) and the critical region of the type II diabetes pancreatic amyloid protein, IAPP (IAPP20-29) were tested. The ratio of affinities of each individual CR analog for the two amyloid fibrils varied considerably. Complexation of certain metal ions (Cu(II), Zn(II), Ni(II), Cd(II)) by a CR analog did not abolish its affinity for amyloid but changed the affinity ratio significantly.
CONCLUSIONS: This study demonstrates that small organic and organometallic molecules are capable of detecting differences in amyloid fibril structure and/or amyloid protein sequence. Molecules of this type could have utility as neuropathological probes or imaging agents, since they are much easier to prepare and functionalize than antibodies and are specific for the fibrillar form of the amyloid proteins.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8807864     DOI: 10.1016/s1074-5521(96)90118-0

Source DB:  PubMed          Journal:  Chem Biol        ISSN: 1074-5521


  12 in total

Review 1.  In vivo amyloid imaging in Alzheimer's disease.

Authors:  H I Sair; P M Doraiswamy; J R Petrella
Journal:  Neuroradiology       Date:  2004-01-23       Impact factor: 2.804

Review 2.  In vivo brain imaging of tangle burden in humans.

Authors:  Gary W Small; Eric D Agdeppa; Vladimir Kepe; Nagichettiar Satyamurthy; Sung-Cheng Huang; Jorge R Barrio
Journal:  J Mol Neurosci       Date:  2002-12       Impact factor: 3.444

3.  Response surface methodology for optimizing the bovine serum albumin fibrillation.

Authors:  Amir Arasteh; Mehran Habibi-Rezaei; Azadeh Ebrahim-Habibi; Ali Akbar Moosavi-Movahedi
Journal:  Protein J       Date:  2012-08       Impact factor: 2.371

4.  A small molecule inhibitor of Pot1 binding to telomeric DNA.

Authors:  Sarah E Altschuler; Johnny E Croy; Deborah S Wuttke
Journal:  Biochemistry       Date:  2012-09-26       Impact factor: 3.162

Review 5.  Polyphenols as Potential Metal Chelation Compounds Against Alzheimer's Disease.

Authors:  Johant Lakey-Beitia; Andrea M Burillo; Giovanni La Penna; Muralidhar L Hegde; K S Rao
Journal:  J Alzheimers Dis       Date:  2021       Impact factor: 4.472

6.  The conformation of the Congo-red ligand bound to amyloid fibrils HET-s(218-289): a solid-state NMR study.

Authors:  Chandrakala Gowda; Giorgia Zandomeneghi; Herbert Zimmermann; Anne K Schütz; Anja Böckmann; Matthias Ernst; Beat H Meier
Journal:  J Biomol NMR       Date:  2017-11-01       Impact factor: 2.835

7.  Detection of amyloid plaques by radioligands for Abeta40 and Abeta42: potential imaging agents in Alzheimer's patients.

Authors:  Mei-Ping Kung; Daniel M Skovronsky; Catherine Hou; Zhi-Ping Zhuang; Tamar L Gur; Bin Zhang; John Q Trojanowski; Virginia M-Y Lee; Hank F Kung
Journal:  J Mol Neurosci       Date:  2003-02       Impact factor: 3.444

8.  The toxic nature of murine amylin and the immune responsivity of pancreatic islet to conformational antibody in mice.

Authors:  Luiza C S Erthal; Luana Jotha-Mattos; Flávio Alves Lara; Sabrina Alves Dos Reis; Bernardo Miguel de Oliveira Pascarelli; Cinthia Melo Costa; Kleber L A Souza; Luís Maurício T R Lima
Journal:  Mol Cell Biochem       Date:  2018-01-25       Impact factor: 3.396

Review 9.  Polyphenols as therapeutic molecules in Alzheimer's disease through modulating amyloid pathways.

Authors:  Johant Lakey-Beitia; Ruben Berrocal; K S Rao; Armando A Durant
Journal:  Mol Neurobiol       Date:  2014-05-15       Impact factor: 5.590

Review 10.  Brain-imaging surrogate markers for detection and prevention of age-related memory loss.

Authors:  Gary W Small
Journal:  J Mol Neurosci       Date:  2002 Aug-Oct       Impact factor: 3.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.